Neurodegeneration in Mesial Temporal Lobe Epilepsy (MTLE) Absence of Alpha-Synuclein and TDP-43 Pathology

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F25%3A00142756" target="_blank" >RIV/00216224:14110/25:00142756 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Neurodegeneration in Mesial Temporal Lobe Epilepsy (MTLE) Absence of Alpha-Synuclein and TDP-43 Pathology

Popis výsledku v původním jazyce

The growing body of evidence concerning the presence of pathological aggregates of hyperphosphorylated tau protein and beta-amyloid in resection specimens from patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE) is well-documented. Recent studies have also suggested alterations in serum levels of alpha-synuclein in this population1,2. Another protein associated with neurodegeneration, TAR DNA-binding protein 43 (TDP-43), has not yet been extensively studied in epilepsy patients. Given this background, the present study aims to investigate the presence of alphasynuclein and TDP-43 pathological aggregates in tissue samples from patients with MTLE sourced from two comprehensive tertiary epilepsy centers

Název v anglickém jazyce

Neurodegeneration in Mesial Temporal Lobe Epilepsy (MTLE) Absence of Alpha-Synuclein and TDP-43 Pathology

Popis výsledku anglicky

The growing body of evidence concerning the presence of pathological aggregates of hyperphosphorylated tau protein and beta-amyloid in resection specimens from patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE) is well-documented. Recent studies have also suggested alterations in serum levels of alpha-synuclein in this population1,2. Another protein associated with neurodegeneration, TAR DNA-binding protein 43 (TDP-43), has not yet been extensively studied in epilepsy patients. Given this background, the present study aims to investigate the presence of alphasynuclein and TDP-43 pathological aggregates in tissue samples from patients with MTLE sourced from two comprehensive tertiary epilepsy centers

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30210 - Clinical neurology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů